Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Glumin 500mg tablets

Dexa Medica

Product packaging may vary from one country to another.

Ingredients in every mg

Metformin 500 mg

Each package contains

5 blisters of 10 tablets

Other details

Dosage formTablet; coated
Flavour None

W.H.O. classification

ATC Level 1 A - Alimentary tract and metabolism
ATC Level 2 A10 - Drugs Used in Diabetes
ATC Level 3 A10B - Blood Glucose Lowering Drugs; excl. Insulins



NOT RECOMMENDEDThis item is not safe for use during pregnancy.


NOT RECOMMENDEDThis item is not safe for use during lactation.


NOT RECOMMENDEDThis item should not be used with alcohol.


SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.

Available in


Dosage information

Dosage: 3 times 1 film-coated tablet per day

Dosage should be increased gradually, one tablet 500 mg three times daily often enough to give a good diabetic control.
Maximum daily dose: 3,000 mg.

When combined with existing sulfonylurea therapy which is not giving adequate control, one tablet of 500 mg metformin HCl should be added initially, with the dosage of metformin HCl being gradually increased until optimal control is obtained.

When metformin HCl is used concomitantly with insulin the guidelines are as follows:
a. When the dosage of insulin is less than 60 units per day, one tablet of 500 mg metformin HCl may be added initially, followed by a gradual reduction of insulin (4 units every 2-4 days). The tablets may be increased at weekly intervals.

b. When the dosage of insulin is more than 60 units per day, the addition of metformin HCl may occasionally cause a rapid fall in the blood sugar level. Careful observation of such patients is advised in the first 24 hours after the introduction of metformin HCl. After this, the recommendations stated previously (point a) should be followed.

Metformin HCl should be given with food or after meal in divided doses.


As mono– or combined therapy with sulphonylurea in patients with Non-insulin-dependent diabetes mellitus (type 2 diabetes) especially if overweight and whose blood glucose level can not be controlled by diet alone.
As an adjuvant therapy in insulin-dependent diabetic patients with hardly controlled symptoms.